To ascertain that the plasma-stable agent 164B8 retained its ability to induce Pin1 degradation in cells, we tested it in three pancreatic cancer cell lines—human BxPC3 and MIA PaCa-2, and the mouse pancreatic cancer cell line KPC—using western blot analysis (Figure 2). This evidence concerns the gene PIN1 and familial pancreatic carcinoma.